Back to Results
First PageMeta Content
Biotechnology / Biology / Medicine / Recombinant proteins / Specialty drugs / Biosimilar / Drugs / Biopharmaceutical / Trastuzumab / Mylan / Pegfilgrastim / Filgrastim


Press Release Mylan & Biocon Announce Regulatory Submission for Proposed Biosimilar Pegfilgrastim Accepted for Review by European Medicines Agency BENGALURU, India and HERTFORDSHIRE, England/PITTSBURGH, USA, July 21, 20
Add to Reading List

Document Date: 2016-07-21 09:25:25


Open Document

File Size: 437,77 KB

Share Result on Facebook
UPDATE